Skip to main content
Year archive

ABL Bio Inc. — 2025 filings

All 56 regulatory filings released by ABL Bio Inc. (298380) in 2025, sourced directly from the official regulator.

56 Filings
2025 Period
2025 filings (56)
Filing Released Lang
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2025-12-26 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2025-11-11 Korean
분기보고서 (2025.09)
Regulatory Filings
2025-11-11 Korean
타법인주식및출자증권취득결정
Regulatory Filings
2025-10-28 Korean
유상증자결정(종속회사의주요경영사항)
Regulatory Filings
2025-10-28 Korean
[기재정정]타법인주식및출자증권취득결정
Regulatory Filings
2025-10-15 Korean
[기재정정]유상증자결정(종속회사의주요경영사항)
Regulatory Filings
2025-10-15 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2025-10-02 Korean
타법인주식및출자증권취득결정
Regulatory Filings
2025-09-26 Korean
유상증자결정(종속회사의주요경영사항)
Regulatory Filings
2025-09-26 Korean
주식매수선택권행사
Share Issue/Capital Change
2025-09-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-09-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-09-09 Korean
투자판단관련주요경영사항(임상시험결과)
Legal Proceedings Report
2025-09-01 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2025-08-26 Korean
반기보고서 (2025.06)
Interim / Quarterly Report H1 2025
2025-08-12 Korean
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (이중항체 면역항암제 ABL103의 제1b/2상 임상시험계획 (IND) 승인)
Legal Proceedings Report
2025-08-08 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-07-23 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-07-23 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-07-23 Korean
전환주식의전환청구권행사
Share Issue/Capital Change
2025-07-14 Korean
투자판단관련주요경영사항 (신규 항체-약물 결합체(ADC) 연구개발을 위한 기술도입 계약 해지)
Regulatory Filings
2025-07-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-07-04 Korean
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (이중항체 면역항암제 ABL103의 제1b/2상 임상시험계획 (IND) 승인 신청)
Legal Proceedings Report
2025-06-11 Korean
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (이중항체 면역항암제 ABL103의 제1b/2상 임상시험계획 (IND) 승인)
Legal Proceedings Report
2025-06-04 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Q1 2025
2025-05-13 Korean
[기재정정]투자판단관련주요경영사항 (IGF1R 기반 BBB 셔틀 플랫폼 GrabodyB(뇌혈관장벽 투과 기술) 기술이전 계약 체결)
Regulatory Filings
2025-05-12 Korean
본점소재지변경
Regulatory Filings
2025-04-28 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정) (이중항체 면역항암제 ABL103의 제1b/2상 임상시험계획 (IND) 승인)
Regulatory Filings
2025-04-24 Korean
투자판단관련주요경영사항 (IGF1R 기반 BBB 셔틀 플랫폼 GrabodyB(뇌혈관장벽 투과 기술) 기술이전 계약 체결)
M&A Activity
2025-04-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-04-04 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-04-04 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-04-04 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-04-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-03-28 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2025-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2025-03-28 Korean
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (이중항체 면역항암제 ABL103의 제1b/2상 임상시험계획 (IND) 승인 신청)
Legal Proceedings Report
2025-03-21 Korean
투자판단관련주요경영사항(임상시험계획승인신청) (이중항체 면역항암제 ABL103의 제1b/2상 임상시험계획 (IND) 승인 신청)
Regulatory Filings
2025-03-19 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2025-03-13 Korean
주주총회집중일개최사유신고
AGM Information
2025-03-13 Korean
사업보고서 (2024.12)
Audit Report / Information FY 2024
2025-03-13 Korean
주주총회소집공고
AGM Information
2025-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2025-03-13 Korean
감사보고서제출
Audit Report / Information FY 2024
2025-03-12 Korean
[기재정정]신규시설투자등
Regulatory Filings
2025-02-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-02-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-02-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-02-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-02-07 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2024
2025-02-07 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-01-17 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-01-17 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-01-17 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2025-01-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-01-03 Korean